Reset filter
Mots-clés
Diagnostic Procedure ×
Afficher plus Mots-clés
Table des matières
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
    1. 7.1. Anestesiología
    1. 7.2. Dermatología
    1. 7.3. ENT
    1. 7.4. Geriatría
    1. 7.5. Ginecología / Obstetricia
    1. 7.6. Medicina Interna
      1. Hematología
      1. Enfermedades infecciosas
      1. Cardiología / Angiología
      1. Neumología
      1. Gastroenterología
      1. Nefrología
      1. Endocrinología / Enfermedades metabólicas
      1. Reumatología
    1. 7.7. Neurología
    1. 7.8. Oftalmología
    1. 7.9. Cuidados paliativos
    1. 7.10. Patología / Forense
    1. 7.11. Pediatría
    1. 7.12. Psiquiatría / Psicosomática
    1. 7.13. Radiología
    1. 7.14. Cirugía
      1. Cirugía General / Visceral
      1. Neurocirugía
      1. Cirugía plástica
      1. Cirugía Torácica
      1. Traumatología / Ortopedia
      1. Cirugía vascular
    1. 7.15. Urología
    1. 7.16. Odontología / OMS
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

22 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

transition dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 16/8/17 - 1 Formulaire, 2 Groupes Item, 4 Eléments de données, 1 Langue
Groupes Item: administrative data, transition dyspnoea index
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

baseline dyspnoea index salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 8/8/17 - 1 Formulaire, 11 Groupes Item, 28 Eléments de données, 1 Langue
Groupes Item: administrative data, baseline dyspnoea index, job, housework, shopping, leisure activities, gardening, social participation, washing, dressing, at rest, other aspect, baseline dyspnoea index score, date
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

visit 1 (medical evaluation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 8/8/17 - 1 Formulaire, 17 Groupes Item, 47 Eléments de données, 1 Langue
Groupes Item: administrative data, demography, medical condition, tobacco use, COPD, oropharyngeal candidasis examination, Chest x-ray, modified medical research council dyspnoea scale, 12-lead ECG, pulmonary function testing, pulmonary funtion testing: FEV1, pulmonary function testing: FVC, pulmonary function testing: FEV1 /FVC ratio, fat free mass, laboratory blood, St. George's respiratory questionnaire, baseline dyspnoea index
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

26672_Common Data Elements Myeloid Leukemia (MDS AML CML) - Global Disease Course

- 20/9/21 - 13 Formulaires, 3 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Global Disease Course, Red Cell Transfusion, Platelet Cell Transfusion
Common Data Elements Myeloid Leukemia (MDS, AML, CML) for use in clinical routine and clinical trial documentation. https://www.ncbi.nlm.nih.gov/pubmed/27577388

Physical Examination/Follow up

3 Groupes Item 14 Eléments de données

Administrative/Demographic Details

1 Groupe Item 11 Eléments de données

Medical History

3 Groupes Item 9 Eléments de données

Lab: Cytology/Cytogenetics/Cytochemistry

1 Groupe Item 29 Eléments de données

Lab: Immunophenotyping

1 Groupe Item 17 Eléments de données

Lab: Molecular Genetics

1 Groupe Item 27 Eléments de données

Acute Myeloid Leukemia - Treatment Details

- 20/9/21 - 13 Formulaires, 6 Groupes Item, 39 Eléments de données, 1 Langue
Groupes Item: Therapeutic procedure; Details, Adverse Event, Hemopoietic stem cell transplant, Platelet Engraftment, Neutrophil Engraftment, Therapeutic procedure; Status
Acute Myeloid Leukemia Common Data Elements Holz

Medical History

6 Groupes Item 20 Eléments de données

Lab: Cytology/Cytogenetics/Cytochemistry

3 Groupes Item 43 Eléments de données

Lab: Molecular Genetics, Immunophenotyping, Cytogenetics

1 Groupe Item 1 Élément de données

Physical Examination/Follow-up

4 Groupes Item 27 Eléments de données

Lab: Infectiology

1 Groupe Item 11 Eléments de données

Lab: Molecular Genetics

1 Groupe Item 23 Eléments de données

clinic internal medicine B SHIP-Trend-1 operational data lung function

- 24/1/21 - 1 Formulaire, 1 Groupe Item, 58 Eléments de données, 2 Langues
Groupe Item: operational data lung function
operational data lung function form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name TREND.TREND1.IMB.LUF.LUFOPD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Gastroenterology activity recording, University Hospital Cologne

- 22/4/17 - 1 Formulaire, 10 Groupes Item, 34 Eléments de données, 1 Langue
Groupes Item: Gastroenterology service, New patient, Follow-up visit, Termination, Chemotherapy, Administration, Counseling, Diagnostics, Procedure, Chemotherapy
Hospital Routine Documentation Subform at the University Hospital Cologne. Original Form name: Leistungserf_Gastro

Gastroenterology Order Form, University Hospital Cologne

- 20/4/17 - 1 Formulaire, 1 Groupe Item, 17 Eléments de données, 1 Langue
Groupe Item: Gastroenterology
Hospital Routine Documentation Subform at the University Hospital Cologne. Original Form name: Gatro_Anforderung

Ewing Study Organ function prior to high dose chemo DRKS00003588 - Organ function prior to high dose chemo

- 4/8/14 - 1 Formulaire, 6 Groupes Item, 14 Eléments de données, 2 Langues
Groupes Item: Show identification of patient, Cardiac function, Glomerular filtration, Tubular function, Liver function, Lung function
EWING 2008, EudraCT 2008-003658-13, http://clinicaltrials.gov/ct2/show/NCT00824083

Eligibility NYHA Class III Heart Failure NCT01162707

- 4/6/17 - 1 Formulaire, 2 Groupes Item, 20 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Wireless, Intermittent Monitoring of Right Heart Pressures in HF; ODM derived from: https://clinicaltrials.gov/show/NCT01162707

Procedure (EHR Archetype) - openEHR-EHR-ACTION.procedure.v1

- 8/7/17 - 1 Formulaire, 1 Groupe Item, 24 Eléments de données, 7 Langues
Groupe Item: openEHR-EHR-ACTION.procedure.v1.xml
Derived from www.openehr.org . Use to record information about the activities required to carry out a procedure, including the planning, scheduling, performance, suspension, cancellation, documentation and completion. This is done by the recording of data against specific activities, as defined by the 'Pathway' careflow steps in this archetype. The scope of this archetype encompasses activities for a broad range of clinical procedures performed for evaluative, investigative, screening, diagnostic, curative, therapeutic or palliative purposes. Examples range from the relatively simple activities, such as insertion of an intravenous cannula, through to complex surgical operations. Additional structured and detailed information about the procedure can be captured using purpose-specific archetypes inserted into the 'Procedure detail' slot, where required. Timings related to a procedure can be managed in one of two ways: - Using the reference model - the time for performance of any pathway step will use the ACTION time attribute for each step. - Archetyped data elements: --- the 'Scheduled date/time' data element is intended to record the precise time when the procedure is planned. Note: the corresponding ACTION time attribute for the Scheduled pathway step will record the time that the procedure was scheduled into a system, not the intended date/time on which the procedure is intended to be carried out; and --- the 'Final end date/time' is intended to record the precise time when the procedure was ended. It can be used to document the complex procedures with multiple components. Note: the corresponding ACTION time attribute for the 'Procedure performed' will document the time each component performed was commenced. This 'Final end date/time' data element will record the date/time of the final active component of the procedure. This will enable a full duration of the active procedure to be calculated. Within the context of an Operation Report, this archetype will be used to record only what was done during the procedure. Separate archetypes will be used to record the other required components of the Operation Report, including the taking of tissue specimen samples, use of imaging guidance, operation findings, post-operative instructions and plans for follow up. Within the context of a Problem list or summary, this archetype may be used to represent procedures that have been performed. The EVALUATION.problem_diagnosis will be used to represent the patient's problems and diagnoses. In practice, many procedures (for example, in ambulatory care) will occur once and not be ordered in advance. The details about the procedure will be added against the pathway step, 'Procedure completed'. In some cases a recurring procedure will be ordered, and in this situation data against the 'Procedure performed' step will be recorded on each occasion, leaving the instruction in the active state. When the last occurrence is recorded the 'Procedure completed' action is recorded showing that this order is now in the completed state. In other situations, such as secondary care, there may be a formal order for a procedure using a corresponding INSTRUCTION archetype. This ACTION archetype can then be used to record the workflow of when and how the order has been carried out. Recording information using this ACTION archetype indicates that some sort of activity has actually occurred; this will usually be the procedure itself but may be a failed attempt or another activity such as postponing the procedure. If there is a formal order for the procedure, the state of this order is represented by the Pathway step against which the data is recorded. For example, using this archetype the progressing state of a Gastroscopy order may be recorded through separate entries in the EHR progress notes at each 'Pathway' step: - record the scheduled Start date/time for the gastroscopy (Procedure scheduled); and - record that the gastroscopy procedure has been completed, including information about the procedure details (Procedure completed). Please note that in the openEHR Reference Model there is a 'Time' attribute, which is intended to record the date and time at which each pathway step of the Action was performed. This is the attribute to use to record the start of the procedure (using the 'Procedure performed' pathway step) or the time that the procedure was aborted (using the 'Procedure aborted' pathway step).

FEES Neurology, University Hospital Cologne

- 20/4/17 - 1 Formulaire, 4 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: FEES, FEES at rest, Evaluation of swallowing without food, Evaluation of swallowing with food
Hospital Routine Documentation Subform at the University Hospital Cologne. Original Form name: FEES_Neurologie

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial